Mast cell ‘stabilisers’ release anti-inflammatory ANX-A1 from mast cells.
Anti-ANX-A1 neutralising Mabs blocked their inhibitory effect.
Mast cells from Anx-A1−/− mice are insensitive to nedocromil or ketotifen.
The effect of ANX-A1 on PGD2 release depends upon the fpr2/3 receptor.
ANX-A1, acting partly through FPR, is a key regulator of mast cell reactivity.